Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lorus Therapeutics Inc completes $7,001,500 prospectus offering of common shares


Tuesday, 10 Dec 2013 09:30am EST 

Lorus Therapeutics Inc:Says it has completed its previously announced public offering of common shares of the company.Says it issued a total of 12,730,000 Offered Shares at a price of $0.55 per Offered Share, for aggregate gross proceeds of $7,001,500.Says the Offering was sold to a syndicate of underwriters co-led by Clarus Securities Inc. and Canaccord Genuity Corp. and including Jennings Capital Inc. and D&D Securities Inc. as well as PowerOne Capital Markets Limited.Says it has granted the Underwriters an over-allotment option to purchase that number of additional common shares equal to 15% of the Offered Shares sold pursuant to the Offering at the Offering Price for a period ending 30 days following the closing of the Offering.Says it intends to use the net proceeds from the offering to fund its clinical trial program, manufacturing program and for general and corporate working capital purposes. 

Company Quote

0.4464
0.0365 +8.90%
12:37pm EDT